Adiponectin, an anti-carcinogenic hormone? A systematic review on breast, colorectal, liver and prostate cancer

Current Medicinal Chemistry

Volumn 19, Issue 32, 2012, Pages 5501-5512

  Perrier, S ^a   Jarde T ^b  

^a AGM Communication   (France)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Adiponectin; Adiponectin signaling; AdipoR1; AdipoR2

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; MAMMALIAN TARGET OF RAPAMYCIN; PROTEIN BAX; PROTEIN BCL 2;

ADIPOSE TISSUE; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BODY MASS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER PREVENTION; CANCER RISK; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN CACO 2; CELL STRAIN HEPG2; COLON MUCOSA; COLORECTAL ADENOMA; COLORECTAL CANCER; HUMAN; IN VITRO STUDY; KNOCKOUT MOUSE; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; PATHOGENESIS; PROSTATE CANCER; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW;

ADIPONECTIN; ANIMALS; HUMANS; NEOPLASMS; RECEPTORS, ADIPONECTIN; RISK FACTORS;

EID: 84870437222     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986712803833137     Document Type: Review

References (121)

1. Maeda, K.; Okubo, K.; Shimomura, I.; Funahashi, T.; Matsuzawa, Y.; Matsubara, K. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem. Biophys. Res. Commun., 1996, 221, 286-289.
2. Nakano, Y.; Tobe, T.; Choi-Miura, N.H.; Mazda, T.; Tomita, M. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem., 1996, 120, 803-812.
3. Scherer, P.E.; Williams, S.; Fogliano, M.; Baldini, G.; Lodish, H.F. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem., 1995, 270, 26746-26749.
4. Hu, E.; Liang, P.; Spiegelman, B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem., 1996, 271, 10697-10703.
5. Kadowaki, T.; Yamauchi, T. Adiponectin and adiponectin receptors. Endocr. Rev., 2005, 26, 439-451.
6. Ebinuma, H.; Miyazaki, O.; Yago, H.; Hara, K.; Yamauchi, T.; Kadowaki, T. A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin. Chim. Acta, 2006, 372, 47-53.
7. Kaser, S.; Tatarczyk, T.; Stadlmayr, A.; Ciardi, C.; Ress, C.; Tschoner, A.; Sandhofer, A.; Paulweber, B.; Ebenbichler, C.F.; Patsch, J.R. Effect of obesity and insulin sensitivity on adiponectin isoform distribution. Eur. J. Clin. Invest., 2008, 38, 827-834.
8. Fruebis, J.; Tsao, T.S.; Javorschi, S.; Ebbets-Reed, D.; Erickson, M.R.; Yen, F.T.; Bihain, B.E.; Lodish, H.F. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U S A, 2001, 98, 2005-2010.
9. Waki, H.; Yamauchi, T.; Kamon, J.; Kita, S.; Ito, Y.; Hada, Y.; Uchida, S.; Tsuchida, A.; Takekawa, S.; Kadowaki, T. Generation of globular fragment of adiponectin by leukocyte elastase secreted by monocytic cell line THP-1. Endocrinology, 2005, 146, 790-796.
10. Yamauchi, T.; Kamon, J.; Ito, Y.; Tsuchida, A.; Yokomizo, T.; Kita, S.; Sugiyama, T.; Miyagishi, M.; Hara, K.; Tsunoda, M.; Murakami, K.; Ohteki, T.; Uchida, S.; Takekawa, S.; Waki, H.; Tsuno, N.H.; Shibata, Y.; Terauchi, Y.; Froguel, P.; Tobe, K.; Koyasu, S.; Taira, K.; Kitamura, T.; Shimizu, T.; Nagai, R.; Kadowaki, T. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature, 2003, 423, 762-769.
11. Jarde, T.; Caldefie-Chezet, F.; Goncalves-Mendes, N.; Mishellany, F.; Buechler, C.; Penault-Llorca, F.; Vasson, M.P. Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies. Endocr. Relat. Cancer, 2009, 16, 1197-1210.
12. Michalakis, K.; Williams, C.J.; Mitsiades, N.; Blakeman, J.; Balafouta-Tselenis, S.; Giannopoulos, A.; Mantzoros, C.S. Serum adiponectin concentrations and tissue expression of adiponectin receptors are reduced in patients with prostate cancer: a case control study. Cancer Epidemiol. Biomarkers Prev., 2007, 16, 308-313.
13. Yoneda, K.; Tomimoto, A.; Endo, H.; Iida, H.; Sugiyama, M.; Takahashi, H.; Mawatari, H.; Nozaki, Y.; Fujita, K.; Yoneda, M.; Inamori, M.; Nakajima, N.; Wada, K.; Nagashima, Y.; Nakagama, H.; Uozaki, H.; Fukayama, M.; Nakajima, A. Expression of adiponectin receptors, AdipoR1 and AdipoR2, in normal colon epithelium and colon cancer tissue. Oncol. Rep., 2008, 20, 479-483.
14. Kershaw, E.E.; Flier, J.S. Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab., 2004, 89, 2548-2556.
15. Arita, Y.; Kihara, S.; Ouchi, N.; Takahashi, M.; Maeda, K.; Miyagawa, J.; Hotta, K.; Shimomura, I.; Nakamura, T.; Miyaoka, K.; Kuriyama, H.; Nishida, M.; Yamashita, S.; Okubo, K.; Matsubara, K.; Muraguchi, M.; Ohmoto, Y.; Funahashi, T.; Matsuzawa, Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, 79-83.
16. Cnop, M.; Havel, P.J.; Utzschneider, K.M.; Carr, D.B.; Sinha, M.K.; Boyko, E.J.; Retzlaff, B.M.; Knopp, R.H.; Brunzell, J.D.; Kahn, S.E. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia, 2003, 46, 459-469.
17. Kadowaki, T.; Sekikawa, A.; Okamura, T.; Takamiya, T.; Kashiwagi, A.; Zaky, W.R.; Maegawa, H.; El-Saed, A.; Nakamura, Y.; Evans, R.W.; Edmundowicz, D.; Kita, Y.; Kuller, L.H.; Ueshima, H. Higher levels of adiponectin in American than in Japanese men despite obesity. Metabolism, 2006, 55, 1561-1563.
18. Paz-Filho, G.; Lim, E.L.; Wong, M.L.; Licinio, J. Associations between adipokines and obesity-related cancer. Front. Biosci., 2011, 16, 1634-1650.
19. Barb, D.; Williams, C.J.; Neuwirth, A.K.; Mantzoros, C.S. Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence. Am. J. Clin. Nutr., 2007, 86, s858-866.
20. Kelesidis, I.; Kelesidis, T.; Mantzoros, C.S. Adiponectin and cancer: a systematic review. Br. J. Cancer, 2006, 94, 1221-1225.
21. Nakayama, S.; Miyoshi, Y.; Ishihara, H.; Noguchi, S. Growth-inhibitory effect of adiponectin via adiponectin receptor 1 on human breast cancer cells through inhibition of S-phase entry without inducing apoptosis. Breast Cancer Res. Treat., 2008, 112, 405-410.
22. Takahata, C.; Miyoshi, Y.; Irahara, N.; Taguchi, T.; Tamaki, Y.; Noguchi, S. Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Lett., 2007, 250, 229-236.
23. Dieudonne, M.N.; Bussiere, M.; Dos Santos, E.; Leneveu, M.C.; Giudicelli, Y.; Pecquery, R. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. Biochem. Biophys. Res. Commun., 2006, 345, 271-279.
24. Treeck, O.; Lattrich, C.; Juhasz-Boess, I.; Buchholz, S.; Pfeiler, G.; Ortmann, O. Adiponectin differentially affects gene expression in human mammary epithelial and breast cancer cells. Br. J. Cancer, 2008, 99, 1246-1250.
25. Grossmann, M.E.; Nkhata, K.J.; Mizuno, N.K.; Ray, A.; Cleary, M.P. Effects of adiponectin on breast cancer cell growth and signaling. Br. J. Cancer, 2008, 98, 370-379.
26. Korner, A.; Pazaitou-Panayiotou, K.; Kelesidis, T.; Kelesidis, I.; Williams, C.J.; Kaprara, A.; Bullen, J.; Neuwirth, A.; Tseleni, S.; Mitsiades, N.; Kiess, W.; Mantzoros, C.S. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. J. Clin. Endocrinol. Metab., 2007, 92, 1041-1048.
27. Dos Santos, E.; Benaitreau, D.; Dieudonne, M.N.; Leneveu, M.C.; Serazin, V.; Giudicelli, Y.; Pecquery, R. Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol. Rep., 2008, 20, 971-977.
28. Kang, J.H.; Lee, Y.Y.; Yu, B.Y.; Yang, B.S.; Cho, K.H.; Yoon, D.K.; Roh, Y.K. Adiponectin induces growth arrest and apoptosis of MDA-MB-231 breast cancer cell. Arch. Pharm. Res., 2005, 28, 1263-1269.
29. Jarde, T.; Perrier, S.; Vasson, M.P.; Caldefie-Chezet, F. Molecular mechanisms of leptin and adiponectin in breast cancer. Eur. J. Cancer, 2011, 47, 33-43.
30. Nkhata, K.J.; Ray, A.; Schuster, T.F.; Grossmann, M.E.; Cleary, M.P. Effects of adiponectin and leptin co-treatment on human breast cancer cell growth. Oncol. Rep., 2009, 21, 1611-1619.
31. Wang, Y.; Lam, J.B.; Lam, K.S.; Liu, J.; Lam, M.C.; Hoo, R.L.; Wu, D.; Cooper, G.J.; Xu, A. Adiponectin modulates the glycogen synthase kinase-3beta/beta-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice. Cancer Res., 2006, 66, 11462-11470.
32. Kim, K.Y.; Baek, A.; Hwang, J.E.; Choi, Y.A.; Jeong, J.; Lee, M.S.; Cho, D.H.; Lim, J.S.; Kim, K.I.; Yang, Y. Adiponectin-activated AMPK stimulates dephosphorylation of AKT through protein phosphatase 2A activation. Cancer Res., 2009, 69, 4018-4026.
33. Taliaferro-Smith, L.; Nagalingam, A.; Zhong, D.; Zhou, W.; Saxena, N.K.; Sharma, D. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Oncogene, 2009, 28, 2621-2633.
34. Li, G.; Cong, L.; Gasser, J.; Zhao, J.; Chen, K.; Li, F. Mechanisms underlying the anti-proliferative actions of adiponectin in human breast cancer cells, MCF7-dependency on the cAMP/protein kinase-A pathway. Nutr. Cancer, 2011, 63, 80-88.
35. Arditi, J.D.; Venihaki, M.; Karalis, K.P.; Chrousos, G.P. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. Horm. Metab. Res., 2007, 39, 9-13.
36. Liu, J.; Lam, J.B.; Chow, K.H.; Xu, A.; Lam, K.S.; Moon, R.T.; Wang, Y. Adiponectin stimulates Wnt inhibitory factor-1 expression through epigenetic regulations involving the transcription factor specificity protein 1. Carcinogenesis, 2008, 29, 2195-2202.
37. Lam, J.B.; Chow, K.H.; Xu, A.; Lam, K.S.; Liu, J.; Wong, N.S.; Moon, R.T.; Shepherd, P.R.; Cooper, G.J.; Wang, Y. Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activities. PLoS One, 2009, 4, e4968.
38. Brakenhielm, E.; Veitonmaki, N.; Cao, R.; Kihara, S.; Matsuzawa, Y.; Zhivotovsky, B.; Funahashi, T.; Cao, Y. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis. Proc. Natl. Acad. Sci. U S A, 2004, 101, 2476-2481.
39. Chen, D.C.; Chung, Y.F.; Yeh, Y.T.; Chaung, H.C.; Kuo, F.C.; Fu, O.Y.; Chen, H.Y.; Hou, M.F.; Yuan, S.S. Serum adiponectin and leptin levels in Taiwanese breast cancer patients. Cancer Lett., 2006, 237, 109-114.
40. Hou, W.K.; Xu, Y.X.; Yu, T.; Zhang, L.; Zhang, W.W.; Fu, C.L.; Sun, Y.; Wu, Q.; Chen, L. Adipocytokines and breast cancer risk. Chin. Med. J. (Engl), 2007, 120, 1592-1596.
41. Kang, J.H.; Yu, B.Y.; Youn, D.S. Relationship of serum adiponectin and resistin levels with breast cancer risk. J. Korean Med. Sci., 2007, 22, 117-121.
42. Mantzoros, C.; Petridou, E.; Dessypris, N.; Chavelas, C.; Dalamaga, M.; Alexe, D.M.; Papadiamantis, Y.; Markopoulos, C.; Spanos, E.; Chrousos, G.; Trichopoulos, D. Adiponectin and breast cancer risk. J. Clin. Endocrinol. Metab., 2004, 89, 1102-1107.
43. Miyoshi, Y.; Funahashi, T.; Kihara, S.; Taguchi, T.; Tamaki, Y.; Matsuzawa, Y.; Noguchi, S. Association of serum adiponectin levels with breast cancer risk. Clin. Cancer Res., 2003, 9, 5699-5704.
44. Tian, Y.F.; Chu, C.H.; Wu, M.H.; Chang, C.L.; Yang, T.; Chou, Y.C.; Hsu, G.C.; Yu, C.P.; Yu, J.C.; Sun, C.A. Anthropometric measures, plasma adiponectin, and breast cancer risk. Endocr. Relat. Cancer, 2007, 14, 669-677.
45. Tworoger, S.S.; Eliassen, A.H.; Kelesidis, T.; Colditz, G.A.; Willett, W.C.; Mantzoros, C.S.; Hankinson, S.E. Plasma adiponectin concentrations and risk of incident breast cancer. J. Clin. Endocrinol. Metab., 2007, 92, 1510-1516.
46. Cust, A.E.; Stocks, T.; Lukanova, A.; Lundin, E.; Hallmans, G.; Kaaks, R.; Jonsson, H.; Stattin, P. The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study. Breast Cancer Res. Treat., 2009, 113, 567-576.
47. Wolf, I.; Sadetzki, S.; Kanety, H.; Kundel, Y.; Pariente, C.; Epstein, N.; Oberman, B.; Catane, R.; Kaufman, B.; Shimon, I. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer, 2006, 106, 966-973.
48. Gaudet, M.M.; Falk, R.T.; Gierach, G.L.; Lacey, J.V., Jr.; Graubard, B.I.; Dorgan, J.F.; Brinton, L.A. Do adipokines underlie the association between known risk factors and breast cancer among a cohort of United States women? Cancer Epidemiol., 2010, 34, 580-586.
49. Karaduman, M.; Bilici, A.; Ozet, A.; Sengul, A.; Musabak, U.; Alomeroglu, M. Tissue levels of adiponectin in breast cancer patients. Med. Oncol., 2007, 24, 361-366.
50. Kaklamani, V.G.; Sadim, M.; Hsi, A.; Offit, K.; Oddoux, C.; Ostrer, H.; Ahsan, H.; Pasche, B.; Mantzoros, C. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res., 2008, 68, 3178-3184.
51. Jarde, T.; Caldefie-Chezet, F.; Damez, M.; Mishellany, F.; Perrone, D.; Penault-Llorca, F.; Guillot, J.; Vasson, M.P. Adiponectin and leptin expression in primary ductal breast cancer and in adjacent healthy epithelial and myoepithelial tissue. Histopathology, 2008, 53, 484-487.
52. Jeong, Y.J.; Bong, J.G.; Park, S.H.; Choi, J.H.; Oh, H.K. Expression of leptin, leptin receptor, adiponectin, and adiponectin receptor in ductal carcinoma in situ and invasive breast cancer. J. Breast Cancer, 2011, 14, 96-103.
53. Sonmez, B.; Seker, M.; Bilici, A.; Yavuz Erkal, F.; Oven Ustaalioglu, B.B.; Gumus, M.; Ozturk Guler, D.; Karaduman, M.; Gezen, C.; Eser, M.; Bildik, N.; Salepci, T. Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients wih breast cancer? J. BUON, 2011, 16, 227-232.
54. Boyd, N.F.; Rommens, J.M.; Vogt, K.; Lee, V.; Hopper, J.L.; Yaffe, M.J.; Paterson, A.D. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol., 2005, 6, 798-808.
55. Maskarinec, G.; Woolcott, C.; Steude, J.S.; Franke, A.A.; Cooney, R.V. The relation of leptin and adiponectin with breast density among premenopausal women. Eur. J. Cancer Prev., 2010, 19, 55-60.
56. Mollerstrom, E.; Kovacs, A.; Lovgren, K.; Nemes, S.; Delle, U.; Danielsson, A.; Parris, T.; Brennan, D.J.; Jirstrom, K.; Karlsson, P.; Helou, K. Upregulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray. BMC Cancer, 2010, 10, 296.
57. Pfeiler, G.; Hudelist, G.; Wulfing, P.; Mattsson, B.; Konigsberg, R.; Kubista, E.; Singer, C.F. Impact of AdipoR1 expression on breast cancer development. Gynecol. Oncol., 2010, 117, 134-138.
58. Byeon, J.S.; Jeong, J.Y.; Kim, M.J.; Lee, S.M.; Nam, W.H.; Myung, S.J.; Kim, J.G.; Yang, S.K.; Kim, J.H.; Suh, D.J. Adiponectin and adiponectin receptor in relation to colorectal cancer progression. Int. J. Cancer, 2010, 127, 2758-2767.
59. Fenton, J.I.; Birmingham, J.M. Adipokine regulation of colon cancer: adiponectin attenuates interleukin-6-induced colon carcinoma cell proliferation via STAT-3. Mol. Carcinog., 2010, 49, 700-709.
60. Habeeb, B.S.; Kitayama, J.; Nagawa, H. Adiponectin supports cell survival in glucose deprivation through enhancement of autophagic response in colorectal cancer cells. Cancer Sci., 2011, 102, 999-1006.
61. Sugiyama, M.; Takahashi, H.; Hosono, K.; Endo, H.; Kato, S.; Yoneda, K.; Nozaki, Y.; Fujita, K.; Yoneda, M.; Wada, K.; Nakagama, H.; Nakajima, A. Adiponectin inhibits colorectal cancer cell growth through the AMPK/mTOR pathway. Int. J. Oncol, 2009, 34, 339-344.
62. Williams, C.J.; Mitsiades, N.; Sozopoulos, E.; Hsi, A.; Wolk, A.; Nifli, A.P.; Tseleni-Balafouta, S.; Mantzoros, C.S. Adiponectin receptor expression is elevated in colorectal carcinomas but not in gastrointestinal stromal tumors. Endocr. Relat. Cancer, 2008, 15, 289-299.
63. Fenton, J.I.; Birmingham, J.M.; Hursting, S.D.; Hord, N.G. Adiponectin blocks multiple signaling cascades associated with leptin-induced cell proliferation in Apc Min/+ colon epithelial cells. Int. J. Cancer, 2008, 122, 2437-2445.
64. Kim, A.Y.; Lee, Y.S.; Kim, K.H.; Lee, J.H.; Lee, H.K.; Jang, S.H.; Kim, S.E.; Lee, G.Y.; Lee, J.W.; Jung, S.A.; Chung, H.Y.; Jeong, S.; Kim, J.B. Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2- mediated AMPK activation. Mol. Endocrinol., 2010, 24, 1441-1452.
65. Zakikhani, M.; Dowling, R.J.; Sonenberg, N.; Pollak, M.N. The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev. Res. (Phila), 2008, 1, 369-375.
66. Fujisawa, T.; Endo, H.; Tomimoto, A.; Sugiyama, M.; Takahashi, H.; Saito, S.; Inamori, M.; Nakajima, N.; Watanabe, M.; Kubota, N.; Yamauchi, T.; Kadowaki, T.; Wada, K.; Nakagama, H.; Nakajima, A. Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut, 2008, 57, 1531-1538.
67. Mutoh, M.; Teraoka, N.; Takasu, S.; Takahashi, M.; Onuma, K.; Yamamoto, M.; Kubota, N.; Iseki, T.; Kadowaki, T.; Sugimura, T.; Wakabayashi, K. Loss of Adiponectin Promotes Intestinal Carcinogenesis in Min and Wildtype Mice. Gastroenterology, 2011, 140, 2000-2008 e2002.
68. Nishihara, T.; Baba, M.; Matsuda, M.; Inoue, M.; Nishizawa, Y.; Fukuhara, A.; Araki, H.; Kihara, S.; Funahashi, T.; Tamura, S.; Hayashi, N.; Iishi, H.; Shimomura, I. Adiponectin deficiency enhances colorectal carcinogenesis and liver tumor formation induced by azoxymethane in mice. World J. Gastroenterol., 2008, 14, 6473-6480.
69. Otani, K.; Kitayama, J.; Yasuda, K.; Nio, Y.; Iwabu, M.; Okudaira, S.; Aoki, J.; Yamauchi, T.; Kadowaki, T.; Nagawa, H. Adiponectin suppresses tumorigenesis in Apc(Min)(/+) mice. Cancer Lett., 2010, 288, 177-182.
70. Ealey, K.N.; Archer, M.C. Elevated circulating adiponectin and elevated insulin sensitivity in adiponectin transgenic mice are not associated with reduced susceptibility to colon carcinogenesis. Int. J. Cancer, 2009, 124, 2226-2230.
71. Nakajima, T.E.; Yamada, Y.; Hamano, T.; Furuta, K.; Matsuda, T.; Fujita, S.; Kato, K.; Hamaguchi, T.; Shimada, Y. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci., 2010, 101, 1286-1291.
72. Otake, S.; Takeda, H.; Fujishima, S.; Fukui, T.; Orii, T.; Sato, T.; Sasaki, Y.; Nishise, S.; Kawata, S. Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J. Gastroenterol., 2010, 16, 1252-1257.
73. Otake, S.; Takeda, H.; Suzuki, Y.; Fukui, T.; Watanabe, S.; Ishihama, K.; Saito, T.; Togashi, H.; Nakamura, T.; Matsuzawa, Y.; Kawata, S. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin. Cancer Res., 2005, 11, 3642-3646.
74. Yamaji, T.; Iwasaki, M.; Sasazuki, S.; Tsugane, S. Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res., 2010, 70, 5430-5437.
75. Erarslan, E.; Turkay, C.; Koktener, A.; Koca, C.; Uz, B.; Bavbek, N. Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig. Dis. Sci., 2009, 54, 862-868.
76. Ferroni, P.; Palmirotta, R.; Spila, A.; Martini, F.; Raparelli, V.; Fossile, E.; Mariotti, S.; Del Monte, G.; Buonomo, O.; Roselli, M.; Guadagni, F. Prognostic significance of adiponectin levels in non-metastatic colorectal cancer. Anticancer Res., 2007, 27, 483-489.
77. Gialamas, S.P.; Petridou, E.T.; Tseleni-Balafouta, S.; Spyridopoulos, T.N.; Matsoukis, I.L.; Kondi-Pafiti, A.; Zografos, G.; Mantzoros, C.S. Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism, 2011.
78. Guadagni, F.; Roselli, M.; Martini, F.; Spila, A.; Riondino, S.; D'Alessandro, R.; Del Monte, G.; Formica, V.; Laudisi, A.; Portarena, I.; Palmirotta, R.; Ferroni, P. Prognostic significance of serum adipokine levels in colorectal cancer patients. Anticancer Res., 2009, 29, 3321-3327.
79. Wei, E.K.; Giovannucci, E.; Fuchs, C.S.; Willett, W.C.; Mantzoros, C.S. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J. Natl. Cancer Inst., 2005, 97, 1688-1694.
80. Lukanova, A.; Soderberg, S.; Kaaks, R.; Jellum, E.; Stattin, P. Serum adiponectin is not associated with risk of colorectal cancer. Cancer Epidemiol. Biomarkers Prev., 2006, 15, 401-402.
81. Stocks, T.; Lukanova, A.; Johansson, M.; Rinaldi, S.; Palmqvist, R.; Hallmans, G.; Kaaks, R.; Stattin, P. Components of the metabolic syndrome and colorectal cancer risk; a prospective study. Int. J. Obes. (Lond), 2008, 32, 304-314.
82. Kemik, O.; Sumer, A.; Kemik, A.S.; Hasirci, I.; Purisa, S.; Dulger, A.C.; Demiriz, B.; Tuzun, S. The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer. World J. Surg. Oncol., 2010, 8, 85.
83. Kaklamani, V.G.; Wisinski, K.B.; Sadim, M.; Gulden, C.; Do, A.; Offit, K.; Baron, J.A.; Ahsan, H.; Mantzoros, C.; Pasche, B. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA, 2008, 300, 1523-1531.
84. Carvajal-Carmona, L.G.; Spain, S.; Kerr, D.; Houlston, R.; Cazier, J.B.; Tomlinson, I. Common variation at the adiponectin locus is not associated with colorectal cancer risk in the UK. Hum. Mol. Genet., 2009, 18, 1889-1892.
85. Pechlivanis, S.; Bermejo, J.L.; Pardini, B.; Naccarati, A.; Vodickova, L.; Novotny, J.; Hemminki, K.; Vodicka, P.; Forsti, A. Genetic variation in adipokine genes and risk of colorectal cancer. Eur. J. Endocrinol., 2009, 160, 933-940.
86. Gornick, M.C.; Rennert, G.; Moreno, V.; Gruber, S.B. Adiponectin gene and risk of colorectal cancer. Br. J. Cancer, 2011, 105, 562-564.
87. Yamamoto, N.; Oshima, T.; Yoshihara, K.; Sato, T.; Yamada, R.; Fujii, S.; Nagano, Y.; Shiozawa, M.; Akaike, M.; Wada, N.; Rino, Y.; Kunisaki, C.; Masuda, M.; Tanaka, K.; Imada, T. Reduced expression of the AdipoR1 gene is correlated with venous invasion in colorectal cancer. Mol. Med. Report, 2009, 2, 555-559.
88. Miyazaki, T.; Bub, J.D.; Uzuki, M.; Iwamoto, Y. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. Biochem. Biophys. Res. Commun., 2005, 333, 79-87.
89. Saxena, N.K.; Fu, P.P.; Nagalingam, A.; Wang, J.; Handy, J.; Cohen, C.; Tighiouart, M.; Sharma, D.; Anania, F.A. Adiponectin modulates C-jun Nterminal kinase and mammalian target of rapamycin and inhibits hepatocellular carcinoma. Gastroenterology, 2010, 139, 1762-1773, 1773 e1761-1765.
90. Man, K.; Ng, K.T.; Xu, A.; Cheng, Q.; Lo, C.M.; Xiao, J.W.; Sun, B.S.; Lim, Z.X.; Cheung, J.S.; Wu, E.X.; Sun, C.K.; Poon, R.T.; Fan, S.T. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFNinducible protein 10/matrix metalloproteinase 9 signaling. Clin. Cancer Res., 2010, 16, 967-977.
91. Sharma, D.; Wang, J.; Fu, P.P.; Sharma, S.; Nagalingam, A.; Mells, J.; Handy, J.; Page, A.J.; Cohen, C.; Anania, F.A.; Saxena, N.K. Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis. Hepatology, 2010, 52, 1713-1722.
92. Berger, E.; Rome, S.; Vega, N.; Ciancia, C.; Vidal, H. Transcriptome profiling in response to adiponectin in human cancer-derived cells. Physiol. Genomics, 2010, 42A, 61-70.
93. Kamada, Y.; Matsumoto, H.; Tamura, S.; Fukushima, J.; Kiso, S.; Fukui, K.; Igura, T.; Maeda, N.; Kihara, S.; Funahashi, T.; Matsuzawa, Y.; Shimomura, I.; Hayashi, N. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model. J. Hepatol., 2007, 47, 556-564.
94. Kotani, K.; Wakai, K.; Shibata, A.; Fujita, Y.; Ogimoto, I.; Naito, M.; Kurozawa, Y.; Suzuki, H.; Yoshimura, T.; Tamakoshi, A. Serum adiponectin multimer complexes and liver cancer risk in a large cohort study in Japan. Asian Pac. J. Cancer Prev., 2009, 10 Suppl, 87-90.
95. Arano, T.; Nakagawa, H.; Tateishi, R.; Ikeda, H.; Uchino, K.; Enooku, K.; Goto, E.; Masuzaki, R.; Asaoka, Y.; Kondo, Y.; Goto, T.; Shiina, S.; Omata, M.; Yoshida, H.; Koike, K. Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients. Int. J. Cancer, 2010.
96. Miuma, S.; Ichikawa, T.; Taura, N.; Shibata, H.; Takeshita, S.; Akiyama, M.; Motoyoshi, Y.; Ozawa, E.; Fujimoto, M.; Kawashimo, H.; Miyaaki, H.; Eguchi, K.; Nakao, K. The level of fasting serum insulin, but not adiponectin, is associated with the prognosis of early stage hepatocellular carcinoma. Oncol. Rep., 2009, 22, 1415-1424.
97. Bub, J.D.; Miyazaki, T.; Iwamoto, Y. Adiponectin as a growth inhibitor in prostate cancer cells. Biochem. Biophys. Res. Commun., 2006, 340, 1158-1166.
98. Davis, R.J. Signal transduction by the JNK group of MAP kinases. Cell, 2000, 103, 239-252.
99. Levy, D.E.; Darnell, J.E., Jr. Stats: transcriptional control and biological impact. Nat. Rev. Mol. Cell. Biol., 2002, 3, 651-662.
100. Luo, Z.; Saha, A.K.; Xiang, X.; Ruderman, N.B. AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci., 2005, 26, 69-76.
101. Barb, D.; Neuwirth, A.; Mantzoros, C.S.; Balk, S.P. Adiponectin signals in prostate cancer cells through Akt to activate the mammalian target of rapamycin pathway. Endocr. Relat. Cancer, 2007, 14, 995-1005.
102. Mistry, T.; Digby, J.E.; Desai, K.M.; Randeva, H.S. Leptin and adiponectin interact in the regulation of prostate cancer cell growth via modulation of p53 and bcl-2 expression. BJU Int., 2008, 101, 1317-1322.
103. Tang, C.H.; Lu, M.E. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate, 2009, 69, 1781-1789.
104. Grossmann, M.E.; Mizuno, N.K.; Bonorden, M.J.; Ray, A.; Sokolchik, I.; Narasimhan, M.L.; Cleary, M.P. Role of the adiponectin leptin ratio in prostate cancer. Oncol. Res., 2009, 18, 269-277.
105. Huffman, D.M.; Johnson, M.S.; Watts, A.; Elgavish, A.; Eltoum, I.A.; Nagy, T.R. Cancer progression in the transgenic adenocarcinoma of mouse prostate mouse is related to energy balance, body mass, and body composition, but not food intake. Cancer Res., 2007, 67, 417-424.
106. Jemal, A.; Center, M.M.; DeSantis, C.; Ward, E.M. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol. Biomarkers Prev., 2010, 19, 1893-1907.
107. Buhmeida, A.; Pyrhonen, S.; Laato, M.; Collan, Y. Prognostic factors in prostate cancer. Diagn. Pathol., 2006, 1, 4.
108. Shaw, G.; Prowse, D.M. Inhibition of androgen-independent prostate cancer cell growth is enhanced by combination therapy targeting Hedgehog and ErbB signalling. Cancer Cell Int., 2008, 8, 3.
109. Schenk, J.M.; Kristal, A.R.; Neuhouser, M.L.; Tangen, C.M.; White, E.; Lin, D.W.; Thompson, I.M. Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. Prostate, 2009, 69, 1303-1311.
110. Arisan, E.D.; Arisan, S.; Atis, G.; Palavan-Unsal, N.; Ergenekon, E. Serum adipocytokine levels in prostate cancer patients. Urol. Int., 2009, 82, 203-208.
111. Goktas, S.; Yilmaz, M.I.; Caglar, K.; Sonmez, A.; Kilic, S.; Bedir, S. Prostate cancer and adiponectin. Urology, 2005, 65, 1168-1172.
112. Sher, D.J.; Oh, W.K.; Jacobus, S.; Regan, M.M.; Lee, G.S.; Mantzoros, C. Relationship between serum adiponectin and prostate cancer grade. Prostate, 2008, 68, 1592-1598.
113. Baillargeon, J.; Platz, E.A.; R ose, D.P.; Pollock, B.H.; Ankerst, D.P.; Haffner, S.; Higgins, B.; Lokshin, A.; Troyer, D.; Hernandez, J.; Lynch, S.; Leach, R.J.; Thompson, I.M. Obesity, adipokines, and prostate cancer in a prospective population-based study. Cancer Epidemiol. Biomarkers Prev., 2006, 15, 1331-1335.
114. Housa, D.; Vernerova, Z.; Heracek, J.; Prochazka, B.; Cechak, P.; Kuncova, J.; Haluzik, M. Adiponectin as a potential marker of prostate cancer progression: studies in organ-confined and locally advanced prostate cancer. Physiol. Res., 2008, 57, 451-458.
115. Li, H.; Stampfer, M.J.; Mucci, L.; Rifai, N.; Qiu, W.; Kurth, T.; Ma, J. A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin. Chem., 2010, 56, 34-43.
116. Freedland, S.J.; Sokoll, L.J.; Platz, E.A.; Mangold, L.A.; Bruzek, D.J.; Mohr, P.; Yiu, S.K.; Partin, A.W. Association between serum adiponectin, and pathological stage and grade in men undergoing radical prostatectomy. J. Urol., 2005, 174, 1266-1270.
117. Dhillon, P.K.; Penney, K.L.; Schumacher, F.; Rider, J.R.; Sesso, H.D.; Pollack, M.; Fiorentino, M.; Finn, S.; Loda, M.; Rifai, N.; Mucci, L.A.; Giovannucci, E.L.; Stampfer, M.J.; Ma, J. Common polymorphisms in the adiponectin and its receptor genes, adiponectin levels and the risk of prostate cancer. Cancer Epidemiol. Biomarkers Prev., 2011.
118. Kaklamani, V.; Yi, N.; Zhang, K.; Sadim, M.; Offit, K.; Oddoux, C.; Ostrer, H.; Mantzoros, C.; Pasche, B. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism, 2011.
119. Beebe-Dimmer, J.L.; Zuhlke, K.A.; Ray, A.M.; Lange, E.M.; Cooney, K.A. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis., 2010, 13, 362-368.
120. Moore, S.C.; Leitzmann, M.F.; Albanes, D.; Weinstein, S.J.; Snyder, K.; Virtamo, J.; Ahn, J.; Mayne, S.T.; Yu, H.; Peters, U.; Gunter, M.J. Adipokine genes and prostate cancer risk. Int. J. Cancer, 2009, 124, 869-876.
121. Mistry, T.; Digby, J.E.; Chen, J.; Desai, K.M.; Randeva, H.S. The regulation of adiponectin receptors in human prostate cancer cell lines. Biochem. Biophys. Res. Commun., 2006, 348, 832-838.